We found that the glioma cells presented a reduced proliferation capacity after gene intervention on CBX7 and CBX8, as indicated by the Ki67 immunostaining in vitro(Figure 6H;, Supplementary Figure S2A). The gene discussed is MKI67; the disease is central nervous system cancer.